International network for natural sciences – research journal
  • mendeley icon
  • linkedin icon
  • google plus icon
  • twitter icon
  • google scholar icon
  • facebook icon

Effect of compositional allicin in garlic bread supplementary diet on patients of stage 1 and 2 hypertension

By: Aqsa Irfan, Shujaat Hussain, Syeda Mahvish Zahra, Aqsa, Kiran Ashraf, Muhammad Tariq Saeed, Shabbir Ahmad

Key Words: Allicin, Blood pressure, Garlic bread, Garlic powder, Hypertension.

Int. J. Biosci. 17(6), 124-138, December 2020.

DOI: http://dx.doi.org/10.12692/ijb/17.6.124-138

Certification: ijb 2020 0094 [Generate Certificate]

Abstract

Prevalence of hypertension is 26 % globally and expected to increase by 29 % till 2025, while in Pakistan its rate is 35 % due to genetic susceptibility, gender, urbanization and secondary life styles in middle ages, which causes heart diseases and stroke. It is the 1st and 3rd dominant cause of death worldwide. Non-pharmacological medication such as use of garlic in diet to reduce hypertension is the main goal in this study. As the bioactive sulfur compound source, garlic consists of S-Allylcysteine. Garlic-derived polysulfide triggers the production of vascular gasotransmitter hydrogen sulphide (H2S) and improves the regulation of endothelial nitric oxide (NO) which encourages smooth muscle relaxation, vasodilatation and blood pressure (BP) reduction. This randomized control study was planned to conclude the effect of garlic bread supplementary diet (GBSD) product on BP in patients with hypertension stage 1 and 2. In total, 2 patients with stage 1 hypertension and 2 with stage 2 hypertension were prescribed with a daily dose of GBSD (containing 600 mg garlic powder n=1 and n=1, respectively) or placebo (n=1 and n=1, respectively) for 12 weeks, were allocated to efficacy analyses. Systolic and diastolic blood pressure values were checked at weeks 4, 8 and 12. During the intervention an eloquent decline of systolic and diastolic BP within the range of 19.5-18.5 and 14.4-13.5 mmHg, respectively compared to placebo specifically during 8 and 12 week, obtained. GBSD was well tolerated, and had a clinically pertinent hypotensive effect in patients with stage 1 and 2 hypertension.

| Views 29 |

| Views 29 |

Effect of compositional allicin in garlic bread supplementary diet on patients of stage 1 and 2 hypertension

Anonymous. 1976. A proposed method for determining glucose using hexokinase and glucose-6-phosphate dehydrogenase. Atlanta: Centers for Disease Control.

Abbas S, Kitchlew AR, Abbas S. 2009. Disease burden of Ischemic Heart Disease in Pakistan and its risk factors. Annals of Pakistan institute of Medical Sciencesa 5(3), 145-50.

Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. (2001). Garlic shows promise for improving some cardiovascular risk factors. Archives of Internal Medicine 161(6), 813-824.

https://doi.org/10.1001/archinte.161.6.813

Adler AJ, Holub BJ. 1997. Effect of garlic and fish oil supplementation on serumlipid and lipoprotein concentrations in hypercholesterol emicmen. The American Journal of clinical nutrition 65(2), 445-450

https://doi.org/10.1093/ajcn/65.2.445

Ahmad ASZ. 2011. Microbiological and chemical quality of dry yeast (Doctoral dissertation, Cairo University).

https://doi.org/10.13140/RG.2.2.23308.82569

Ali M, Al-Qattan KK, Al-Enezi F, Khanafer R. MA, Mustafa T. 2000. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins, Leukotrienes and Essential Fatty Acids 62(4), 253-259. ALK Trading LLC, Nutritional composition of TAVRIA naturals Wheat Flour, Accessed 2019 jan;

https://doi.org/10.1054/plef.2000.0152

https://alktrading.m.trustpass.alibaba.com/?spm=a2706.7835515.0.0.10243a8emBwvRL

Allain CC, Poon LS, Chan CS, Richmond WFPC, Fu PC. 1974. Enzymatic determination of total serum cholesterol. Clinical chemistry 20(4), 470-475.

https://doi.org/10.1093/clinchem/20.4.470

Al-Qattan KK, Khan I, Alnaqeeb MA, Ali M. 2003. Mechanism of garlic (Allium sativum) induced reduction of hypertension in 2K-1C rats: a possible mediation of Na/H exchanger isoform-1. Prostaglandins, Leukotrienes and Essential Fatty Acids 69(4), 217-222.

https://doi.org/10.1016/S0952-3278(03)00087-5

Al-Qattan, Khaled K, Martha Thomson Sausan Al-Mutawa’a, Dalal Al-Hajeri, Hana Drobiova, Muslim Ali. 2006. Nitric oxide mediates the blood-pressure lowering effect of garlic in the rat two-kidney, one-clip model of hypertension. The Journal of nutrition 136, no. 3: 774S-776S.

https://doi.org/10.1093/jn/136.3.774S

Amundson DM, Zhou M. 1999. Fluorometric method for the enzymatic determination of cholesterol. Journal of biochemical and biophysical methods 38(1), 43-52.

https://doi.org/10.1016/S0165-022X(98)00036-0

Ashraf R, Khan RA, Ashraf I, Qureshi AA. 2013. Effects of Allium sativum (garlic) on systolic and diastolic blood pressure in patients with essential hypertension. Pakistan journal of pharmaceutical sciences 26(5).

Auer W, Eiber A, Hertkorn E, Hoehfeld E, Koehrle U, Lorenz A, Schmid-Otto B. 1990. Hypertension and hyperlipidaemia: garlic helps in mild cases. British journal of clinical practice. Supplement 69, 3-6.

Barthelmai W, Czok R, Klin Wochenscht. 1962. 40, 585.

Benavides Gloria A, Giuseppe Squadrito L, Robert Mills W, Hetal Patel D, Scott Isbell T, Rakesh Patel P, Victor Darley-Usmar M, Jeannette Doeller E, David Kraus W.  2007. Hydrogen sulfide mediates the vasoactivity of garlic. Proceedings of the National Academy of Sciences 104(46), 17977-17982.

https://doi.org/10.1073/pnas.0705710104

Bhardwaj K, Verma MK, Verma N, Bhardwaj, S, Mishra S. 2015. Effect of long term supplementation of active garlic allicin in reducing blood pressure in hypertensive subjects. International Journal of Advances in Medicine 2, 231-234.

https://doi.org/10.18203/2349-3933.ijam20150550

Borrelli F, Capasso R, Izzo AA. 2007. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Molecular nutrition & food research 51(11), 1386-1397.

https://doi.org/10.1002/mnfr.200700072

Briganti EM, McNeil JJ, Shaw JE, Zimmet PZ., Chadban SJ, Atkins RC, Welborn TA. 2003. Untreated hypertension among Australian adults: the 1999–2000 Australian diabetes, obesity and lifestyle study (AusDiab). Medical Journal of Australia 179(3), 135-139.

https://doi.org/10.5694/j.1326-5377.2003.tb05471.x

Camargo JL, Gross JL. 2004. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. Journal of clinical pathology 57(4), 346-349.

http://dx.doi.org/10.1136/jcp.2002.007088

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr, JL, Roccella EJ. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. The Journal of the American Medical Association 289(19), 2560-2571.

https://doi.org/10.1001/jama.289.19.2560

Chockalingam A. 2007. Impact of world hypertension day. Canadian Journal of Cardiology 23(7), 517-51

https://doi.org/10.1016/S0828-282X(07)70795-X

Chockalingam A. 2008. World Hypertension Day and global awareness. Canadian Journal of Cardiology 24(6), 441-444.

https://doi.org/10.1016/S0828-282X(08)70617-2

Chuah, Shin Chet, Philip K. Moore, Yi Zhun Zhu. 2007. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. American Journal of Physiology-Heart and Circulatory Physiology 293, no. 5, H2693-H2701.

https://doi.org/10.1152/ajpheart.00853.2007

De A, Santos OS, Gruenwald J. 1993. Effect of garlic powder tablets on blood lipids and blood pressure-a six month placebo controlled, double blind study. British Journal of Clinical Research 4, 37-37.

Dos Santos Ferreira CE, França CN, Correr CJ, Zucker ML, Andriolo A, Scartezini M. 2015. Clinical correlation between a point-of-care testing system and laboratory automation for lipid profile. Clinica Chimica Acta 446, 263-266.

https://doi.org/10.1016/j.cca.2015.04.036

Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Rosenthal T. 2001. The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats. American journal of hypertension 14(4), 377-381.

https://doi.org/10.1016/S0895-7061(00)01298-X

Elkayam A, Peleg E, Grossman E, Shabtay Z, Sharabi Y. 2013. Effects of allicin on cardiovascular risk factors in spontaneously hypertensive rats. Israel Medical Association Journal 15(3), 170-3.

Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. 2009. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. Journal of public health 31(1), 47-58.

https://doi.org/10.1093/pubmed/fdn078

Fagard, RH. 2012. Resistant hypertension. Heart, 98(3), 254-261.

http://dx.doi.org/10.1136/heartjnl-2011-300741

Ford CD, Kim MJ, Dancy BL. 2009. Perceptions of hypertension and contributing personal and environmental factors among rural Southern African American women. Ethnicity & disease 19(4), 407.

Förstermann Ulrich, William Sessa C. 2012. Nitric oxide synthases: regulation and function.  European heart journal 33(7), 829-837.

https://doi.org/10.1093/eurheartj/ehr304

García-Trejo E, Arellano-Buendía AS, Argüello-García R, Loredo-Mendoza ML, García-Arroyo FE, Arellano-Mendoza MG, Osorio-Alonso H. 2016. Effects of allicin on hypertension and cardiac function in chronic kidney disease. Oxidative medicine and cellular longevity.

https://doi.org/10.1155/2016/3850402

Hamwi A, Schweiger CR, Veitl M, Schmid R. 1995. Quantitative Measurement of HbAlc by an Immunoturbidimetric Assay Compared to a Standard HPLC Method. American journal of clinical pathology 104(1), 89-95.

https://doi.org/10.1093/ajcp/104.1.89

Handel EV, Zilversmit DB. 1957. Micromethod for the direct determination of serum triglycerides. Journal of Laboratory and Clinical Medicine 50(152), I957.

Henry JB. 1979. Clinical diagnosis and management by laboratory methods. Philadelphia: W.B. Saunders and Company, 153.

Heyward VH, Stolarczyk LM. 2000. Avaliação da composição corporal aplicada. Heze Duomei Yeast Co., Ltd. Nutritional composition of Instant Dry Yeast, Accessed 2019 Jan;

https://dmyeast.m.en.allibaba.com/?spm=a2706.7835515.0.0.51115657ZgRy8c

Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, Black HR. 1998. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Archives of internal medicine 158(11), 1189-1194.

https://doi:10.1001/archinte.158.11.1189

Jafar TH, Jessani S, Jafary FH, Ishaq M, Orkazai R, Orkazai S, Chaturvedi N. 2005. General practitioners’ approach to hypertension in urban Pakistan: disturbing trends in practice. Circulation 111(10), 1278-1283.

https://doi.org/10.1161/01.CIR.0000157698.78949.D7

Jain AK, Vargas R, Gotzkowsky S, McMahon FG. 1993. Can garlic reduce levels of serum lipids? A controlled clinical study. The American journal of medicine 94(6), 632-635.

https://doi.org/10.1016/0002-9343(93)90216-C

Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The 6th Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Archives of internal medicine 157, 2413 -2446.

Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Schork MA. 2006. Feasibility of treating prehypertension with an angiotensin-receptor blocker. New England Journal of Medicine 354(16), 1685-1697.

Kandziora J. 1988. The blood pressure lowering and lipid lowering effect of a garlic preparation in combination with a diuretic. Arzl Forsch, 3, 1-8.

Kannel WB. 1995. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertension Research, 18(3), 181-196.

https://doi.org/10.1291/hypres.18.181

Kashfi, Khosrow, Kenneth Olson R. 2013. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras.” Biochemical pharmacology 85(5), 689-703.

https://doi.org/10.1016/j.bcp.2012.10.019

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. 2005. Global burden of hypertension: analysis of worldwide data. The lancet 365(9455), 217-223.

https://doi.org/10.1016/S0140-6736(05)17741-1

Khoo YSK, Aziz Z. 2009. Garlic supplementation and serum cholesterol: a meta‐analysis. Journal of clinical pharmacy and therapeutics 34(2), 133-145.

https://doi.org/10.1111/j.1365-2710.2008.00998.x

Kumar P, Yadava RK, Gollen B, Kumar S, Verma RK, Yadav S. 2011. Nutritional contents and medical properties of wheat: a review. Life Sciences and Medical Research 22, 1-10.

Lambert M, Neish AC. 1950. Rapid method for estimation of glycerol in fermentation solutions. Canadian Journal of Research 28(3), 83-89.

https://doi.org/10.1139/cjr50b-013

Lanzotti V. 2006. The analysis of onion and garlic. Journal of chromatography A, 1112(1-2), 3-22.

https://doi.org/10.1016/j.chroma.2005.12.016

Lawson, Larry D, Christopher D. Gardner. Composition, stability, and bioavailability of garlic products used in a clinical trial.” Journal of agricultural and food chemistry53(16), 6254-6261.
https://doi.org/10.1021/jf050536

Macan H, Uykimpang R, Alconcel M, Takasu, J, Razon R, Amagase H, Niihara Y. 2006. Aged garlic extract may be safe for patients on warfarin therapy. The Journal of nutrition, 136(3), 793S-795S.

https://doi.org/10.1093/jn/136.3.793S

Majzunova Miroslava Ima Dovinova, Miroslav Barancik, Julie YH Chan. 2013. Redox signaling in pathophysiology of hypertension.” Journal of biomedical science 20(1), 69.

https://doi.org/10.1186/1423-0127-20-69

Mariam MBB, Devi UC. 2016. Chemical and shelf life analysis of dry garlic powder: A golden herb. International Journal of Agriculture and Food Science Technology 7(1), 1-6.

McInnes GT. 2005. Lowering blood pressure for cardiovascular risk reduction. Journal of hypertension 23, S3-S8.

MITR PHOL SUGAR CORP. LTD. 2019 Jan; Nutritional compositions of Mitr Phol Caster Sugar, Accessed.

https://mitrpholsugar.m.trustpass.alibaba.com/?spm=a2706.7835515.0.0.734d1967L0Kjdy

Montezano Augusto C, Rhian Touyz M. 2012. Reactive oxygen species and endothelial function–role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic & clinical pharmacology & toxicology 110(1), 87-94.

https://doi.org/10.1111/j.1742-7843.2011.00785.x

Nakasone Y, Nakamura Y, Yamamoto T, Yamaguchi H. 2013. Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Experimental and therapeutic medicine 5(2), 399-405.

https://doi.org/10.3892/etm.2012.819

Okada Y, Tanaka K, Sato E, Okajima H. 2006. Kinetic and mechanistic studies of allicin as an antioxidant. Organic & Biomolecular Chemistry 4(22), 4113-4117.

https://doi.org/10.1039/B611506C

Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon III RO. 1995. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91(6), 1732-8.

https://doi.org/10.1161/01.CIR.91.6.1732

Predmore, Benjamin Lee, David Joseph Lefer, Gabriel Gojon. 2012. Hydrogen sulfide in biochemistry and medicine.” Antioxidants & redox signaling 17(1), 119-140.

https://doi.org/10.1089/ars.2012.4612

Rahman K. 2001. Historical perspective on garlic and cardiovascular disease. The journal of nutrition 131(3), 977S-979S.

https://doi.org/10.1093/jn/131.3.977S

Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. 2008. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Annals of Pharmacotherapy 42(12), 1766-1771.

https://doi.org/10.1345/aph.1L319

Ried K, Frank OR, Stocks NP. 2010. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas, 67(2), 144-150.

https://doi.org/10.1016/j.maturitas.2010.06.001

Ried K, Frank OR, Stocks NP. 2013. Aged garlic extract reduces blood pressure in hypertensives: a dose–response trial. European Journal of Clinical Nutrition 67(1), 64-70.

https://doi.org/10.1038/ejcn.2012.178

Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. 2008. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC cardiovascular disorders 8(1), 13.

https://doi.org/10.1186/1471-2261-8-13

Sharifi AM, Darabi R, Akbarloo N. 2003. Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat. Journal of ethnopharmacology 86(2-3), 219-224.

https://doi.org/10.1016/S0378-8741(03)00080-1

Silagy CA, Neil HA. 1994. A meta-analysis of the effect of garlic on blood pressure.

https://doi.org/10.1097/00004872-199404000-00017

Sobenin IA, Andrianova IV, Fomchenkov IV, Gorchakova TV, Orekhov AN. 2009. Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension. Hypertension Research 32(6), 433-437.

https://doi.org/10.1038/hr.2009.36

Tanaka S, Watabe K, Yamaguchi H. 2012. Studies on the mechanism of antihypertensive action of a garlic homogenate-based diet ‘Dento Ninniku Ran-ou’using isolated rat aorta preparations. Oyo Yakuri (Pharmacometrics) 82, 21-28.

Tanaka S, Watabe K, Ubukata K., & Yamaguchi H. 2006. 71-10 Antihypertensive Effects of” Garlic-egg” Powder and g-Glutamyl-S-Allyl-Cysteine (GSAC), in Spontaneously Hypertensive Rats. Oyo Yakuri-Pharmacometrics, 71(3-4), 73-78.

Turner B, Mølgaard C, Marckmann P. 2004. Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. British journal of

nutrition 92(4), 701-706.

https://doi.org/10.1079/BJN20041255

Volpe M, Tocci G. 2010. Rethinking targets of blood pressure and guidelines for hypertension clinical management. Nephrology Dialysis Transplantation 25(11), 3465-3471.

https://doi.org/10.1093/ndt/gfq492

Vora CK, Mansoor GA. 2005. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Current hypertension reports 7(4), 275-280.

https://doi.org/10.1007/s11906-005-0025-0

Vorberg G, Schneider B. 1990. Therapy with garlic: results of a placebo-controlled, double-blind study. British journal of clinical practice. Supplement 69, 7-11.

Wang Rui. 2012. “Physiological implications of hydrogen sulfide: a whiff exploration that blossomed.” Physiological reviews 92(2), 791-896.

https://doi.org/10.1152/physrev.00017.2011

Watabe K. 2006. Studies on the mechanism of antihypertensive action of a constituent of garlic, γ-glutamyl-S-allyl-cysteine (GSAC).  Pharmacometrics 71, 79-87.

Williams MJ, Sutherland WH, McCormick M. P, Yeoman DJ, de Jong SA. 2005. Aged garlic extract improves endothelial function in men with coronary artery disease. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives 19(4), 314-319.

https://doi.org/10.1002/ptr.1663

Zhang XH, Lowe D, Giles P, Fell S, Board AR, Baughan JA, Maslin DJ. 2001. A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners. Blood coagulation & fibrinolysis 12(1), 67-74.

Aqsa Irfan, Shujaat Hussain, Syeda Mahvish Zahra, Aqsa, Kiran Ashraf, Muhammad Tariq Saeed, Shabbir Ahmad.
Effect of compositional allicin in garlic bread supplementary diet on patients of stage 1 and 2 hypertension.
Int. J. Biosci. 17(6), 124-138, December 2020.
https://innspub.net/ijb/effect-compositional-allicin-garlic-bread-supplementary-diet-patients-stage-1-2-hypertension/
Copyright © 2020
By Authors and International Network for
Natural Sciences (INNSPUB)
https://innspub.net
brand
innspub logo
english language editing
  • CALL FOR PAPERS
    CALL FOR PAPERS
    Publish Your Article
  • CALL FOR PAPERS
    CALL FOR PAPERS
    Submit Your Article
INNSPUB on FB
Email Update